buthionine sulfoximine has been researched along with Lymphoma, Mantle-Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernstein, SH; Brookes, PS; Casulo, C; Dai, Y; Grant, S; Hilchey, SP; Kiebala, M; Maggirwar, SB; Peterson, DR; Skalska, J | 1 |
1 other study(ies) available for buthionine sulfoximine and Lymphoma, Mantle-Cell
Article | Year |
---|---|
Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach.
Topics: Antimetabolites; Antineoplastic Agents; Auranofin; B-Lymphocytes; Buthionine Sulfoximine; Cell Death; Cell Line, Tumor; Cell Survival; Drug Synergism; Gene Expression Regulation, Neoplastic; Glutathione; Humans; Lymphoma, Mantle-Cell; Molecular Targeted Therapy; NF-kappa B; Oxidation-Reduction; Oxidative Stress; Primary Cell Culture; Signal Transduction; Thioredoxin-Disulfide Reductase; Thioredoxins | 2015 |